Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-18 Sale | 2025-02-20 4:52 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 18,322 | $80.31 | $1,471,394 | 118,863 (Direct) | View |
| 2025-02-11 Sale | 2025-02-13 5:09 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 18,321 | $80 | $1,465,680 | 137,185 (Direct) | View |
| 2025-02-06 Sale | 2025-02-07 5:10 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 28,390 | $80.9 | $2,296,751 | 155,506 (Direct) | View |
| 2025-01-07 Sale | 2025-01-10 6:45 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 6,000 | $65.43 | $392,602 | 150,793 (Direct) | View |
| 2024-05-28 Sale | 2024-05-30 5:41 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 241,288 | $50 | $12,064,607 | 652,609 (Direct) | View |
| 2024-05-14 Sale | 2024-05-15 4:32 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 11,088 | $25.32 | $280,748 | 188,641 (Direct) | View |
| 2024-01-09 Sale | 2024-01-11 4:07 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 4,497 | $29.18 | $131,222 | 114,051 (Direct) | View |
| 2023-12-22 Sale | 2023-12-22 4:03 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 13,199 | $30 | $395,970 | 105,241 (Direct) | View |
| 2023-05-15 Sale | 2023-05-17 4:09 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 3,820 | $18.95 | $72,390 | 117,619 (Direct) | View |
| 2023-01-10 Sale | 2023-01-12 4:08 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 2,857 | $18.12 | $51,769 | 66,031 (Direct) | View |
| 2022-05-16 Sale | 2022-05-18 4:10 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 1,433 | $18.51 | $26,525 | 54,683 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:41 pm | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 1,154 | $25.11 | $28,977 | 35,979 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-05 Option Award | 2025-02-07 5:10 pm | N/A N/A | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 65,033 | $0 | 155,506 (Direct) | View |
| 2025-01-08 Option Award | 2025-01-10 6:45 pm | N/A 2035-01-08 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 38,587 | $0 | 150,793 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:30 pm | N/A 2034-06-13 | Xilio Therapeutics Inc. | XLO | Bonstein Sara Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 5:00 pm | N/A 2034-06-11 | scPharmaceuticals Inc. | SCPH | Bonstein Sara Director | 19,750 | $0 | 19,750 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 5:41 pm | N/A N/A | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 23,565 | $26.43 | 652,609 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 5:41 pm | N/A N/A | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 28,500 | $34.03 | 652,609 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 5:41 pm | N/A N/A | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 30,528 | $24.7 | 652,609 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 5:41 pm | N/A N/A | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 80,185 | $28.88 | 652,609 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 5:41 pm | N/A 2030-02-03 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 241,288 | $0 | 652,609 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 5:41 pm | N/A N/A | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 42,900 | $26.46 | 652,609 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 5:41 pm | N/A N/A | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 35,610 | $17.07 | 652,609 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-15 4:32 pm | N/A 2034-05-13 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 85,678 | $0 | 188,641 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 5:27 pm | N/A 2034-01-04 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 76,433 | $0 | 182,108 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 4:30 pm | N/A 2033-06-11 | Xilio Therapeutics Inc. | XLO | Bonstein Sara Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:15 pm | N/A 2033-06-06 | scPharmaceuticals Inc. | SCPH | Bonstein Sara Director | 17,300 | $0 | 17,300 (Direct) | View |
| 2023-05-11 Option Award | 2023-05-15 4:08 pm | N/A 2033-05-11 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 213,818 | $0 | 279,849 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 4:17 pm | N/A 2033-01-05 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 51,057 | $0 | 106,648 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:30 pm | N/A 2032-06-14 | Xilio Therapeutics Inc. | XLO | Bonstein Sara Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:30 pm | N/A 2032-06-14 | scPharmaceuticals Inc. | SCPH | Bonstein Sara Director | 16,300 | $0 | 16,300 (Direct) | View |
| 2022-05-11 Option Award | 2022-05-13 6:12 pm | N/A 2032-05-11 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 115,097 | $0 | 151,076 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 5:08 pm | N/A 2032-01-06 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 75,846 | $0 | 99,973 (Direct) | View |
Ownership | 2021-10-21 8:45 pm | N/A 2031-08-22 | Xilio Therapeutics Inc. | XLO | Bonstein Sara Director | 0 | $0 | 53,213 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 4:45 pm | N/A 2031-06-08 | scPharmaceuticals Inc. | SCPH | Bonstein Sara Director | 16,300 | $0 | 16,300 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-14 5:07 pm | N/A 2031-05-12 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 82,812 | $0 | 91,995 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-08 4:40 pm | N/A 2031-01-07 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 54,783 | $0 | 54,783 (Direct) | View |
| 2020-07-08 Option Award | 2020-07-13 4:15 pm | N/A 2030-07-08 | scPharmaceuticals Inc. | SCPH | Bonstein Sara Director | 12,248 | $0 | 12,248 (Direct) | View |
| 2020-05-12 Option Award | 2020-05-14 8:58 pm | N/A 2030-05-12 | INSMED Inc | INSM | Bonstein Sara Chief Financial Officer | 34,890 | $0 | 34,890 (Direct) | View |